Literature DB >> 20827394

Gene therapy to the kidney using viral vectors.

Talha Akbulut1, Frank Park.   

Abstract

Many pediatric diseases have reached a therapeutic plateau using currently available surgical and pharmacological approaches. Gene therapy has emerged as an exciting new technology to manipulate cells in the mammalian system, and in some cases, this method has achieved amazing therapeutic benefits. Compared to other organs, such as the brain, liver and lung, methods to genetically modify renal cells have received relatively little attention. The current review will discuss the challenges and important developments regarding gene therapy to the kidney, and relate the recent successes and failures to the future potential of gene therapy as a treatment modality in the context of pediatric disease.

Entities:  

Year:  2008        PMID: 20827394      PMCID: PMC2935311     

Source DB:  PubMed          Journal:  Paidiatrike        ISSN: 0377-2551


  94 in total

1.  Efficient gene transfer to rat renal glomeruli with recombinant adenoviral vectors.

Authors:  X Ye; X Liu; Z Li; P E Ray
Journal:  Hum Gene Ther       Date:  2001-01-20       Impact factor: 5.695

Review 2.  Gene therapy: future or flop.

Authors:  Frank Park; Kenneth W Gow
Journal:  Pediatr Clin North Am       Date:  2006-08       Impact factor: 3.278

3.  In vivo gene transfer to kidney by lentiviral vector.

Authors:  G Luca Gusella; Elena Fedorova; Daniele Marras; Paul E Klotman; Mary E Klotman
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.

Authors:  P Heikkila; T Parpala; O Lukkarinen; M Weber; K Tryggvason
Journal:  Gene Ther       Date:  1996-01       Impact factor: 5.250

5.  Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis.

Authors:  Chiang-Ting Chien; Chien Chiang-Ting; Tzu-Ching Chang; Chang Tzu-Ching; Ching-Yi Tsai; Tsai Ching-Yi; Song-Kuen Shyue; Shyue Song-Kuen; Ming-Kuen Lai; Lai Ming-Kuen
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

6.  A novel surgical organ perfusion method for effective ex vivo and in vivo gene transfer into renal glomerular cells.

Authors:  T Parpala-Spårman; O Lukkarinen; P Heikkilä; K Tryggvason
Journal:  Urol Res       Date:  1999-04

Review 7.  Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.

Authors:  Peter Manilla; Tessio Rebello; Cathleen Afable; Xiaobin Lu; Vladimir Slepushkin; Laurent M Humeau; Kathy Schonely; Yajin Ni; Gwendolyn K Binder; Bruce L Levine; Rob-Roy MacGregor; Carl H June; Boro Dropulic
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

8.  Adeno-associated viral vector transduction of green fluorescent protein in kidney: effect of unilateral ureteric obstruction.

Authors:  Keiichi Ito; Jie Chen; Jonathan J Khodadadian; E Darracott Vaughan; Michael Lipkowitz; Dix P Poppas; Diane Felsen
Journal:  BJU Int       Date:  2008-02       Impact factor: 5.588

9.  Nonviral gene delivery to the rat kidney with polyethylenimine.

Authors:  A Boletta; A Benigni; J Lutz; G Remuzzi; M R Soria; L Monaco
Journal:  Hum Gene Ther       Date:  1997-07-01       Impact factor: 5.695

10.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  1 in total

1.  [A method for efficient transduction of miR-483-5p in the kidney of mice].

Authors:  Ying Xia; Xue-Juan Zhou; Wen-Qing Gu; Yan-Yan Zhao; Xiao Xiao; Xiao-Chun Bai; Jun Liu; Ming Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.